Dr. Adriana Albini is an experienced professional at the European Institute for Oncology (IEO) in Milan. She was previously a Full Professor of Immunology/General Pathology at the Department of Medicine, University of Milan Bicocca. She has a Ph.D. in Chemistry and trained from 1980 to 1983 as a biochemist and postdoctoral fellow at the Max Planck Institute for Biochemistry, Martinsried bei Muenchen, Germany. In 2018, she was elected to the Board of Directors of the AACR (American Association for Cancer Research), and since 2021 she has been Chair of the "Cancer Prevention Working Group" of the AACR (American Association for Cancer Research). She is a member of the Scientific Committee of the ESO (European School of Oncology). Additionally, she has been President of the Italian Society for Cancer Research (SIC) and President of the Metastasis Research Society (MRS). She is the President-Elect of EWMD Italy (European Women Management and Development). Moreover, she is a member of the following editorial boards of scientific journals: Journal of the National Cancer Institute, Carcinogenesis, Molecular Cancer Therapeutics, and Cancer Prevention Research. Her main focuses are in vitro and in vivo models for angiogenesis and inflammation, vascular biology, microenvironments, and mechanisms of invasion of endothelial cells. Her major interest is cancer prevention and interception.